286
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

The Effect of Grapefruit Intake on Endogenous Serum Estrogen Levels in Postmenopausal Women

, , &
Pages 644-652 | Received 01 Oct 2012, Accepted 11 Apr 2013, Published online: 16 Jul 2013

REFERENCES

  • Bailey , D G and Dresser , G K . 2004 . Interactions between grapefruit juice and cardiovascular drugs . Am J Cardiovasc Drugs , 4 : 281 – 297 .
  • Maskalyk , J . 2002 . Grapefruit juice: potential drug interactions . Can Med Assoc J , 167 : 279 – 280 .
  • Dahan , A and Altman , H . 2004 . Food-drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance . Eur J Clin Nutr , 58 : 1 – 9 .
  • Edgar , B , Bailey , D , Bergstrand , R , Johnsson , G and Regardh , C G . 1992 . Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine—and its potential clinical relevance . Eur J Clin Pharmacol , 42 : 313 – 317 .
  • Lundahl , J , Regardh , C G , Edgar , B and Johnsson , G . 1997 . Effects of grapefruit juice ingestion—pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men . Eur J Clin Pharmacol , 52 : 139 – 145 .
  • Lundahl , J U , Regardh , C G , Edgar , B and Johnsson , G . 1998 . The interaction effect of grapefruit juice is maximal after the first glass . Eur J Clin Pharmacol , 54 : 75 – 81 .
  • Greenblatt , D J , von Moltke , L L , Harmatz , J S , Chen , G Weemhoff , J L . 2003 . Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice . Clin Pharmacol Ther , 74 : 121 – 129 .
  • Bailey , D G , Dresser , G K , Kreeft , J H , Munoz , C Freeman , D J . 2000 . Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients . Clin Pharmacol Ther , 68 : 468 – 477 .
  • Fukuda , K , Guo , L , Ohashi , N , Yoshikawa , M and Yamazoe , Y . 2000 . Amounts and variation in grapefruit juice of the main components causing grapefruit–drug interaction . J Chromatogr B Biomed Sci Appl , 741 : 195 – 203 .
  • Lown , K S , Bailey , D G , Fontana , R J , Janardan , S K Adair , C H . 1997 . Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression . J Clin Invest , 99 : 2545 – 2553 .
  • Paine , M F , Widmer , W W , Hart , H L , Pusek , S N Beavers , K L . 2006 . A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction . Am J Clin Nutr , 83 : 1097 – 1105 .
  • Medical Letter . 2005 . Drug interactions with grapefruit juice . Obstet Gynecol , 105 : 429 – 431 .
  • Schubert , W , Cullberg , G , Edgar , B and Hedner , T . 1994 . Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women . Maturitas , 20 : 155 – 163 .
  • Weber , A , Jager , R , Borner , A , Klinger , G Vollanth , R . 1996 . Can grapefruit juice influence ethinylestradiol bioavailability? . Contraception , 53 : 41 – 47 .
  • Endogenous Hormones and Breast Cancer Collaborative Group . 2002 . Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies . J Natl Cancer Inst , 94 : 606 – 616 .
  • Monroe , K R , Murphy , S P , Kolonel , L N and Pike , M C . 2007 . Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort Study . Br J Cancer , 97 : 440 – 445 .
  • Kim , E H , Hankinson , S E , Eliassen , A H and Willett , W C . 2008 . A prospective study of grapefruit and grapefruit juice intake and breast cancer risk . Br J Cancer , 98 : 240 – 241 .
  • Spencer , E A , Key , T J , Appleby , P N , van Gils , C H Olsen , A . 2009 . Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) . Cancer Causes Control , 20 : 803 – 809 .
  • Probst-Hensch , N M , Ingles , S A , Diep , A T , Haile , R W Stanczyk , F Z . 1999 . Aromatase and breast cancer susceptibility . Endocr Relat Cancer , 6 : 165 – 173 .
  • Slater , C C , Hodis , H N , Mack , W J , Shoupe , D Paulson , R J . 2001 . Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women . Menopause , 8 : 200 – 203 .
  • Monroe , K R , Murphy , S P , Henderson , B E , Kolonel , L N Stanczyk , F Z . 2007 . Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the multiethnic cohort study . Nutr Cancer , 58 : 127 – 135 .
  • Hankinson , S E , Manson , J E , Spiegelman , D , Willett , W C Longcope , C . 1995 . Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period . Cancer Epidemiol Biomarkers Prev , 4 : 649 – 654 .
  • Baglietto , L , Severi , G , English , D R , Krishnan , K Hopper , J L . 2010 . Circulating steroid hormone levels and risk of breast cancer for postmenopausal women . Cancer Epidemiol Biomarkers Prev , 19 : 492 – 502 .
  • Pasqualini , J R . 2004 . The selective estrogen enzyme modulators in breast cancer: a review . Biochim Biophys Acta , 1654 : 123 – 143 .
  • Suzuki , T , Miki , Y , Nakamura , Y , Moriya , T Ito , K . 2005 . Sex steroid-producing enzymes in human breast cancer . Endocr Relat Cancer , 12 : 701 – 720 .
  • Pasqualini , J R and Chetrite , G S . 2005 . Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer . J Steroid Biochem Mol Biol , 93 : 221 – 236 .
  • Kulendran , M , Salhab , M and Mokbel , K . 2009 . Oestrogen-synthesising enzymes and breast cancer . Anticancer Res , 29 : 1095 – 1109 .
  • Pasqualini , J R . 2009 . Breast cancer and steroid metabolizing enzymes: the role of progestogens . Maturitas , 65 ( Suppl 1 ) : S17 – S21 .
  • Chetrite , G S , Thomas , J L , Shields-Botella , J , Cortes-Prieto , J Philippe , J C . 2005 . Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues . Anticancer Res , 25 : 2827 – 2830 .
  • Lonning , P E , Haynes , B P , Straume , A H , Dunbier , A Helle , H . 2011 . Exploring breast cancer estrogen disposition: the basis for endocrine manipulation . Clin Cancer Res , 17 : 4948 – 4958 .
  • Messer , A , Nieborowski , A , Strasser , C , Lohr , C and Schrenk , D . 2011 . Major furocoumarins in grapefruit juice I: levels and urinary metabolite(s) . Food Chem Toxicol , 49 : 3224 – 3231 .
  • Wanwimolruk , S and Marquez , P V . 2006 . Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California . Drug Metabol Drug Interact , 21 : 233 – 243 .
  • Widmer , W and Haun , C . 2005 . Variation in furanocoumarin content and new furanocoumarin dimers in commercial grapefruit (Citrus paradisi Macf.) juices . J Food Sci , 70 : C307 – C312 .
  • Hanley , M J , Cancalon , P , Widmer , W W and Greenblatt , D J . 2011 . The effect of grapefruit juice on drug disposition . Expert Opin Drug Metab Toxicol , 7 : 267 – 286 .
  • Seden , K , Dickinson , L , Khoo , S and Back , D . 2010 . Grapefruit–drug interactions . Drugs , 70 : 2373 – 2407 .
  • Tapaninen , T , Neuvonen , P J and Niemi , M . 2010 . Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate Aliskiren . Clin Pharmacol Ther , 88 : 339 – 342 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.